KalVista Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q2 2024.
  • KalVista Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending July 31, 2024 was -$40.4M, a 59.7% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending July 31, 2024 was -$142M, a 48.9% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$127M, a 36.3% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$92.9M, a 12.8% decline from 2021.
  • KalVista Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$82.3M, a 78.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$142M -$40.4M -$15.1M -59.7% May 1, 2024 Jul 31, 2024 10-Q 2024-09-05
Q1 2024 -$127M -$44.6M -$18.3M -69.7% Feb 1, 2024 Apr 30, 2024 10-K 2024-07-11
Q4 2023 -$108M -$29M -$7.73M -36.3% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 -$101M -$27.7M -$5.39M -24.2% Aug 1, 2023 Oct 31, 2023 10-Q 2024-03-11
Q2 2023 -$95.2M -$25.3M -$2.28M -9.87% May 1, 2023 Jul 31, 2023 10-Q 2024-09-05
Q1 2023 -$92.9M -$26.3M -$2.19M -9.09% Feb 1, 2023 Apr 30, 2023 10-K 2024-07-11
Q4 2022 -$90.7M -$21.3M +$1.16M +5.18% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
Q3 2022 -$91.9M -$22.3M -$2.61M -13.3% Aug 1, 2022 Oct 31, 2022 10-Q 2024-03-11
Q2 2022 -$89.3M -$23M -$6.93M -43% May 1, 2022 Jul 31, 2022 10-Q 2024-03-11
Q1 2022 -$82.3M -$24.1M -$9.16M -61.2% Feb 1, 2022 Apr 30, 2022 10-K 2024-07-11
Q4 2021 -$73.2M -$22.5M -$12.4M -124% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-09
Q3 2021 -$60.8M -$19.7M -$9.22M -88.5% Aug 1, 2021 Oct 31, 2021 10-Q 2023-03-09
Q2 2021 -$51.5M -$16.1M -$5.3M -49% May 1, 2021 Jul 31, 2021 10-Q 2023-03-09
Q1 2021 -$46.2M -$15M -$8.37M -127% Feb 1, 2021 Apr 30, 2021 10-K 2023-07-10
Q4 2020 -$37.9M -$10M -$757K -8.15% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-10
Q3 2020 -$37.1M -$10.4M -$4.52M -76.6% Aug 1, 2020 Oct 31, 2020 10-Q 2022-03-10
Q2 2020 -$32.6M -$10.8M -$3.48M -47.4% May 1, 2020 Jul 31, 2020 10-Q 2022-03-10
Q1 2020 -$29.1M -$6.59M +$1.94M +22.8% Feb 1, 2020 Apr 30, 2020 10-K 2020-07-01
Q4 2019 -$31.1M -$9.29M -$5.34M -135% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-11
Q3 2019 -$25.7M -$5.9M -$2.6M -78.7% Aug 1, 2019 Oct 31, 2019 10-Q 2021-03-11
Q2 2019 -$23.1M -$7.34M -$2.31M -45.9% May 1, 2019 Jul 31, 2019 10-Q 2021-03-11
Q1 2019 -$20.8M -$8.53M -$7.87M -1198% Feb 1, 2019 Apr 30, 2019 10-K 2020-07-01
Q4 2018 -$12.9M -$3.96M +$1.28M +24.4% Nov 1, 2018 Jan 31, 2019 10-K 2020-07-01
Q3 2018 -$14.2M -$3.3M +$1.68M +33.7% Aug 1, 2018 Oct 31, 2018 10-K 2020-07-01
Q2 2018 -$15.9M -$5.03M -$102K -2.07% May 1, 2018 Jul 31, 2018 10-K 2020-07-01
Q1 2018 -$15.8M -$657K +$3.55M +84.4% Feb 1, 2018 Apr 30, 2018 10-K 2019-07-16
Q4 2017 -$19.4M -$5.23M +$2.41M +31.5% Nov 1, 2017 Jan 31, 2018 10-K 2019-07-16
Q3 2017 -$21.8M -$4.99M -$2.6M -109% Aug 1, 2017 Oct 31, 2017 10-K 2019-07-16
Q2 2017 -$19.2M -$4.93M +$2.42M +33% May 1, 2017 Jul 31, 2017 10-K 2019-07-16
Q1 2017 -$21.6M -$4.2M +$2.41M +36.4% Feb 1, 2017 Apr 30, 2017 10-K 2018-07-30
Q4 2016 -$24M -$7.64M -$1.99M -35.1% Nov 1, 2016 Jan 31, 2017 10-K 2018-07-30
Q3 2016 -$22M -$2.39M +$2.61M +52.2% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-08
Q2 2016 -$24.6M -$7.35M +$1.66M +18.4% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-12
Q1 2016 -$26.3M -$6.61M -$1.42M -27.5% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$24.8M -$5.66M -$945K -20% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 -$23.9M -$4.99M -$996K -24.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$22.9M -$9.01M -$6.38M -242% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$16.5M -$5.18M -$3.17M -157% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$13.4M -$4.71M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$4M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-30
Q2 2014 -$2.64M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-30
Q1 2014 -$2.02M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.